MOTS-c

What is MOTS-c?

MOTS-c (mitochondrial open reading frame of the twelve-S rRNA type-c) is a small peptide of 16 amino acids that the body encodes not in the nucleus but within the mitochondrial genome itself. This unusual origin puts it in a class of molecules known as mitochondrial-derived peptides, which act as signals between the mitochondria and the rest of the cell.

Interest in MOTS-c centers on its role as a metabolic regulator: circulating levels appear to change with exercise, age, and metabolic stress. It is not an FDA-approved drug. In the United States any clinical use is as a physician-supervised, pharmacy-compounded preparation, and the human evidence base is still in its early stages.

How MOTS-c works

MOTS-c's best-studied action is activation of AMP-activated protein kinase (AMPK), the cell's central energy sensor. When AMPK is switched on, cells shift toward burning fuel — taking up glucose, oxidizing fatty acids, and improving how efficiently energy is used — which is broadly the same pathway that exercise and metabolic drugs like metformin engage.

Preclinical work also describes MOTS-c translocating to the cell nucleus under metabolic stress, where it is proposed to influence stress-response and antioxidant gene programs. Through these combined effects it is often described as an exercise-mimetic — a signal that reproduces some of the metabolic adaptations normally driven by physical activity — but this framing rests largely on animal and cell studies.

What MOTS-c is used for

What the evidence shows

The bulk of MOTS-c evidence comes from cell and animal studies. In mice, MOTS-c has been shown to improve insulin sensitivity, protect against diet-induced obesity, and enhance metabolic flexibility, with AMPK activation as the recurring mechanism [1][2].

Human data are far more limited. Observational work shows that circulating MOTS-c rises with exercise and differs across metabolic states, which supports its biological relevance, but there are no large, published randomized controlled trials establishing that administering MOTS-c produces meaningful clinical benefit in people [2][3].

We are candid about that gap. MOTS-c is a mechanistically compelling molecule with strong preclinical support and genuinely thin human efficacy data — a distinction that matters when you are deciding whether it fits your goals, and one we walk through directly rather than overselling.

Dosing & administration context

MOTS-c is typically administered by subcutaneous injection, with protocols in clinical use described in cycles rather than continuous daily use. Because rigorous human dosing trials are absent, any regimen is extrapolated from preclinical work and clinical experience rather than from established evidence.

The specific dose, frequency, and cycle length are individualized by the prescribing physician based on your goals, metabolic labs, and response — which is why we frame this as clinical context, not a self-dosing guide. MOTS-c bought as research-only vials or gray-market powder carries no guarantee of identity, purity, or sterility.

MOTS-c is not an FDA-approved medication. Content on this page is clinical context for physician-supervised, pharmacy-compounded use — not a dosing guide or a substitute for medical advice.

Safety & side effects

MOTS-c has a limited human safety record, so its profile is characterized mainly from preclinical studies, where it has generally been well tolerated. Reported effects in clinical use tend to be mild and centered on the injection itself.

Because long-term human safety data do not yet exist, we screen carefully before prescribing and monitor throughout a cycle — including relevant metabolic labs. As with any compounded peptide, source control matters: a product from a licensed 503A/503B pharmacy is a fundamentally different risk profile than an unregulated research vial.

How Strong Health prescribes MOTS-c

At Strong Health, MOTS-c is prescribed only after a physician evaluation that includes your metabolic history and, where relevant, labs such as fasting glucose, insulin, and lipids. It is dispensed exclusively through licensed 503A or 503B compounding pharmacies under physician orders; we do not sell or recommend research-only product.

We treat MOTS-c as one input into a metabolic and longevity plan, not a shortcut around nutrition, training, and sleep. Your physician sets the protocol, reviews your labs and response at scheduled intervals, and adjusts or stops treatment based on how your metabolism actually responds — and will tell you plainly where the evidence is still thin.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions